User profiles for M. Waligora

Marcin Waligora

Professor at Jagiellonian University Medical College
Verified email at uj.edu.pl
Cited by 853

Evaluating progression-free survival as a surrogate outcome for health-related quality of life in oncology: a systematic review and quantitative analysis

…, L Xie, L Tsoi, M Waligora, M Prasad… - JAMA Internal …, 2018 - jamanetwork.com
Importance Progression-free survival (PFS) has become a commonly used outcome to assess
the efficacy of new cancer drugs. However, it is not clear if delay in progression leads to …

Google search as an additional source in systematic reviews

J Piasecki, M Waligora, V Dranseika - Science and engineering ethics, 2018 - Springer
Marko Curkovic in his letter (2017) points out that using Google Search in our systematic
review (Piasecki et al. 2017) could have led to the so-called “bubble effect”, a form of selection …

A systematic review of how patients value COPD outcomes

…, M Waligóra, A Agarwal, M Ventresca… - European …, 2018 - Eur Respiratory Soc
Our objective was to summarise systematically all research evidence related to how
patients value outcomes in chronic obstructive pulmonary disease (COPD). We conducted a …

Left ventricular function during and after right ventricular pacing

M Nahlawi, M Waligora, SM Spies, RO Bonow… - Journal of the American …, 2004 - jacc.org
Objectives : The aim of this research was to evaluate right ventricular pacing effects on left
ventricular function. Background : Right ventricular pacing alters the ventricular activation …

[HTML][HTML] Research in disaster settings: a systematic qualitative review of ethical guidelines

S Mezinska, P Kakuk, G Mijaljica, M Waligóra… - BMC medical …, 2016 - Springer
Background Conducting research during or in the aftermath of disasters poses many specific
practical and ethical challenges. This is particularly the case with research involving human …

[HTML][HTML] Characterization of patients with pulmonary arterial hypertension: data from the Polish Registry of Pulmonary Hypertension (BNP-PL)

…, M Waligóra, S Darocha, M Furdal… - Journal of clinical …, 2020 - mdpi.com
Current knowledge of pulmonary arterial hypertension (PAH) epidemiology is based mainly
on data from Western populations, and therefore we aimed to characterize a large group of …

[HTML][HTML] Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: a multicentre registry

…, A Pietrasik, R Pietura, J Stępniewski, M Waligóra… - …, 2022 - ncbi.nlm.nih.gov
… Our patients had higher body mass index (27.4±5.3 vs 22.3±3.4 kg/m 2 ) than the Japanese
patient population25 and presented a significant number of conditions predisposing for …

Characteristics and outcomes of patients with chronic thromboembolic pulmonary hypertension in the era of modern therapeutic approaches: Data from the Polish …

…, M Waligóra, M Roik, M Grabka… - … in Chronic Disease, 2021 - journals.sagepub.com
… The mean 6MWD was 334 ± 166.4 m, the mean NT-proBNP level was 1482 ± 3130 pg/ml, …
Marcin Waligóra has nothing to declare. Marek Roik has nothing to declare. Marek Grabka …

[HTML][HTML] Child's assent in research: Age threshold or personalisation?

M Waligora, V Dranseika, J Piasecki - BMC medical ethics, 2014 - Springer
Background Assent is an important ethical and legal requirement of paediatric research.
Unfortunately, there are significant differences between the guidelines on the details of assent. …

[HTML][HTML] Umbrella and basket trials in oncology: ethical challenges

K Strzebonska, M Waligora - BMC medical ethics, 2019 - Springer
Background Novel precision oncology trial designs, such as basket and umbrella trials, are
designed to test new anticancer agents in more effective and affordable ways. However, they …